Colloidal aggregation confounds cell-based Covid-19 antiviral screens

Isabella S Glenn1, Lauren N Hall1, Mir M Khalid2,3

  • 1Department of Pharmaceutical Chemistry, University of California San Francisco (UCSF), San Francisco, CA, USA.

Summary

Colloidal aggregation in drug candidates can cause false positives in COVID-19 antiviral screens. Pre-saturation with BSA or detergents can reveal true drug efficacy by disrupting these aggregates.